- Home
- DOCS
DOCS
Doximity Inc.
as 07-26-2024 4:00pm EST
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 5.2B | IPO Year: | 2021 |
| Target Price: | $27.70 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.72 | EPS Growth: | 35.85 |
| 52 Week Low/High: | $19.71 - $36.03 | Next Earning Date: | 08-08-2024 |
| Revenue: | $475,422,000 | Revenue Growth: | 13.45% |
| Revenue Growth (this year): | 9.91% | Revenue Growth (next year): | 9.05% |
Stock Insider Trading Activity of Doximity Inc. (DOCS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wampler Kira Scherer | DOCS | Director | Jul 1 '24 | Sell | $28.00 | 2,500 | $70,000.00 | 10,258 | SEC Form 4 |
| Bryson Anna | DOCS | Chief Financial Officer | Jun 12 '24 | Sell | $30.00 | 15,000 | $450,000.00 | 288,685 | SEC Form 4 |
| Cabral Timothy S | DOCS | Director | Jun 12 '24 | Sell | $30.00 | 10,000 | $300,000.00 | 10,258 | SEC Form 4 |
| Bryson Anna | DOCS | Chief Financial Officer | Jun 12 '24 | Sell | $30.00 | 15,000 | $450,006.00 | 288,685 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Jun 3 '24 | Sell | $27.99 | 2,500 | $69,975.00 | 10,258 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | May 17 '24 | Sell | $27.22 | 2,500 | $68,050.00 | 10,258 | SEC Form 4 |
| Overpeck Craig | DOCS | See Remarks | May 15 '24 | Sell | $23.85 | 1,500 | $35,775.00 | 108,609 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Apr 1 '24 | Sell | $26.97 | 2,500 | $67,425.00 | 10,258 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Mar 1 '24 | Sell | $27.88 | 2,500 | $69,700.00 | 10,258 | SEC Form 4 |
| Overpeck Craig | DOCS | See Remarks | Feb 15 '24 | Sell | $30.02 | 1,500 | $45,030.00 | 112,971 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Feb 1 '24 | Sell | $27.05 | 2,500 | $67,625.00 | 10,258 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Jan 2 '24 | Sell | $28.27 | 5,000 | $141,330.50 | 10,258 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Dec 14 '23 | Sell | $26.00 | 2,500 | $65,000.00 | 10,258 | SEC Form 4 |
| Wampler Kira Scherer | DOCS | Director | Dec 14 '23 | Sell | $26.65 | 2,500 | $66,625.00 | 10,258 | SEC Form 4 |
| Overpeck Craig | DOCS | See Remarks | Nov 15 '23 | Sell | $25.23 | 1,500 | $37,845.00 | 116,470 | SEC Form 4 |
Latest Doximity Inc. News
DOCS Breaking Stock News: Dive into DOCS Ticker-Specific Updates for Smart Investing
Zacks
9 hours ago
3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases
Zacks
2 days ago
Doximity (DOCS) Stock Moves -1.24%: What You Should Know
Argus Research
3 days ago
DOCS: Lowering target price to $30.00
Investing.com
6 days ago
Street calls of the week: Upgrades for Apple and Shopify; downgrade for Doximity
Business Wire
8 days ago
Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024
MT Newswires
8 days ago
Doximity Shares Fall After Wells Fargo Downgrade
Zacks
9 days ago
Doximity (DOCS) Stock Moves -1.23%: What You Should Know
Argus Research
10 days ago
DOCS: Raising target price to $31.00
Compare DOCS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DOCS Doximity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.